In particular, GFRα1 expression was upregulated compared to normal breast tissue in almost 60% of breast cancer patients sampled and this upregulation was correlated with estrogen receptor (ER)-positive breast cancer cases [26,27]. Here, ESR1 is linked to breast carcinoma.